SANOFI INDIA
|
The Current P/S Ratio of SANOFI INDIA is 6.89.
Share Price | ₹8,536.5 | May 06,2024 |
Market Cap | ₹19,634.0 Cr | |
Sales-TTM | ₹2,851.1 Cr | TTM-Standalone Results |
Price/Sales | 6.89x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of SANOFI INDIA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹19,634.0 Cr] as on May 06,2024
(/) Sales [ ₹2,851.1 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 6.89x ]
Thus, for SANOFI INDIA , the investors are currently willing to pay '6.89 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SANOFI INDIA !
The chart below summarizes the trend in P/S Ratio of SANOFI INDIA over the last five years.
Historical PS (Price/Sales) ratio chart of SANOFI INDIA
PS Ratio Performance Analysis for SANOFI INDIA
- SANOFI INDIA 's p/e ratio for fiscal years ending Dec2023 to Dec2019 averaged 5.87x.
- SANOFI INDIA 's operated at median p/e ratio of 6.14x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SANOFI INDIA 's p/e ratio peaked in Dec2020 at 6.59x.
- SANOFI INDIA 's p/e ratio hit its five-year low in Dec2022 of 4.86x.
How does SANOFI INDIA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
SANOFI INDIA | 2,851.1 | 6.89 | 19,634.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 47,444.6 | 7.74 | 367,026.0 |
CIPLA LTD | 25,350.2 | 4.53 | 114,925.0 |
DR REDDYS LABORATORIES LTD | 27,212.5 | 3.86 | 105,109.0 |
ZYDUS LIFESCIENCES LTD | 19,024.2 | 5.40 | 102,736.0 |
DIVIS LABORATORIES LTD | 7,492.8 | 14.03 | 105,128.0 |
MANKIND PHARMA LTD | 9,946.3 | 9.20 | 91,490.4 |
TORRENT PHARMACEUTICALS LTD | 10,474.0 | 8.77 | 91,906.5 |
LUPIN LTD | 19,480.1 | 3.93 | 76,554.6 |
AUROBINDO PHARMA LTD | 27,894.7 | 2.44 | 68,144.7 |
ABBOTT INDIA LTD | 5,753.4 | 9.52 | 54,743.4 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SANOFI INDIA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.44x |
Max industry PS | 14.03x |
Median industry PS | 6.89x |
Average industry PS | 6.94x |
You may also like the below Video Courses